1. Microbiology and Infectious Disease
Download icon

Science Writing Competition: Rolling back malaria

  1. Philippa C Matthews  Is a corresponding author
  1. University of Oxford, United Kingdom
Feature Article
  • Cited 0
  • Views 692
  • Annotations
Cite this article as: eLife 2015;4:e07364 doi: 10.7554/eLife.07364


Efforts to fight malaria in Africa are proving successful in many countries, but a population explosion means that there is still a long way to go.

Main text

This article by Philippa C Matthews (pictured) was the winning entry in the 2015 Access to Understanding science-writing competition organized by the British Library in partnership with eLife and Europe PMC. Access to Understanding promotes understanding of biomedical research. Competition entrants were challenged to summarize selected scientific research articles in plain English, explaining why the research was done, what was done and why it is important.

Plasmodium falciparum is the most deadly of all malaria parasites. Children are particularly vulnerable to the devastating consequences of this infection, and the World Health Organisation (WHO) estimates that a child in Africa dies from malaria every minute (WHO, 2014). In recognition of this crisis, malaria has become a headline priority in global health, with campaigns such as the Roll Back Malaria initiative spearheading a huge international effort to tackle the disease.

Abdisalan Noor and colleagues set out to assess how much progress has been made across Africa in the Roll Back Malaria era. Have the immense resources deployed made a real difference to some of the world's most vulnerable populations? How has the burden of malaria altered in the decade since 2000? And can we identify whether infection risks have changed by country or region? With these questions in mind, Noor and colleagues developed a method to measure the changing patterns of malaria risk in Africa as precisely as possible (Noor et al., 2014).

The symptoms of malaria can mimic those of many other infections, and suspected cases of malaria are often treated in the absence of a definite diagnosis and without attending a hospital or clinic. For these reasons, trying to get a clear picture of the scale of the malaria problem in Africa is a major challenge. Noor and colleagues chose to measure malaria by the most accurate method available, which involved looking for studies that had actually identified P. falciparum parasites in the blood. Their final analysis draws on data collected from 3.5 million individuals from over 26,000 surveys spanning 49 regions of Africa, with each piece of information linked to its precise geographic origin by satellite technology.

The researchers—who are based at the Kenya Medical Research Institute-Wellcome Trust Research Programme in Nairobi, Oxford University and the WHO Regional Office for Africa in the Republic of Congo—fed this vast mine of data into a carefully constructed computational analysis. Each piece of information was adjusted to account for when and where it was collected, and the data were then standardized to work out the rate of infection in the age group of interest—the highly vulnerable population of children aged 2–10 years. They also factored in a host of complex influences on malaria transmission, such as urbanisation and climate. The final output was a measure of malaria risk for each individual square kilometre of Africa, first in 2000 and again a decade later. Each of these tiny squares was then classified into one of eight different malaria risk categories.

From this analysis, Noor and colleagues report several substantial and encouraging improvements in the patterns of malaria in Africa. Strikingly, they calculated that 217 million people in Africa were living in a lower risk area in 2010 than they did in 2000. They also found an overall reduction in malaria transmission in 40 of the 44 countries that they assessed in detail. Moreover, four territories—South Africa, Eritrea, Ethiopia and Cape Verde—had successfully reduced malaria into the lowest risk category by 2010. By this time, the majority of the transmission in the highest risk category was occurring in just ten countries.

However, the results also provide a sobering insight into the effects of the population explosion in Africa. This has increased the total numbers of people at risk of malaria; worryingly, over 50% of the population still live in regions of substantial risk. Rates of infection have also remained unchanged or have increased in some countries between 2000 and 2010: Malawi and South Sudan are highlighted as areas for increasing concern, and high transmission has continued across many parts of Nigeria and the Democratic Republic of Congo.

Noor and colleagues also report some areas of difficulty. Despite a data collection effort that spanned eight years, they were still unable to find enough information to assess the malaria risk for certain regions of Africa. Moreover, the vastly complex nature of malaria transmission cannot be completely captured or measured by a computer-based method. Overall, however, the results of this analysis provide valuable feedback for organizations trying to improve population health in many parts of Africa.

As well as amassing a vast amount of information about the distribution of malaria, the researchers also thought hard about the impact of the rapidly changing social and geographical landscape of Africa, ranging from urbanisation to changes in rainfall patterns. The detailed maps they have produced also highlight how the risks of an infection can wax and wane, reminding us of the need to constantly re-assess the best way to keep pace with changing patterns of disease. Noor and colleagues conclude with cautious optimism about the progress made since 2000, but provide a timely warning that the challenge of malaria is far from over.


    1. WHO
    (2014) Malaria Fact Sheet: Number 94
    Available at: http://www.who.int/mediacentre/factsheets/fs094/en/.

Article and author information

Author details

  1. Philippa C Matthews

    NIHR Academic Clinical Lecturer in the Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    For correspondence
    Competing interests
    The author declares that no competing interests exist.

Publication history

  1. Version of Record published: March 30, 2015 (version 1)


© 2015, Matthews

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 692
    Page views
  • 64
  • 0

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Zachary F Mandell et al.
    Research Article

    NusA and NusG are transcription factors that stimulate RNA polymerase pausing in Bacillus subtilis. While NusA was known to function as an intrinsic termination factor in B. subtilis, the role of NusG in this process was unknown. To examine the individual and combinatorial roles that NusA and NusG play in intrinsic termination, Term-seq was conducted in wild type, NusA depletion, DnusG, and NusA depletion DnusG strains. We determined that NusG functions as an intrinsic termination factor that works alone and cooperatively with NusA to facilitate termination at 88% of the 1400 identified intrinsic terminators. Our results indicate that NusG stimulates a sequence-specific pause that assists in the completion of suboptimal terminator hairpins with weak terminal A-U and G-U base pairs at the bottom of the stem. Loss of NusA and NusG leads to global misregulation of gene expression and loss of NusG results in flagella and swimming motility defects.

    1. Microbiology and Infectious Disease
    Jinfeng Cai et al.
    Research Article

    The major barrier to curing HIV-1 infection is a small pool of latently infected cells that harbor replication-competent viruses, which are widely considered the origin of viral rebound when ART is interrupted. The difficulty of distinguishing latently infected cells from the vast majority of uninfected cells has represented a significant bottleneck precluding comprehensive understandings of HIV-1 latency. Here we reported and validated a newly-designed dual fluorescent reporter virus, DFV-B, infection with which in primary CD4+ T cells can directly label latently infected cells and generate a latency model that was highly physiological relevant. Applying DFV-B infection in Jurkat T cells, we generated a stable cell line model of HIV-1 latency with diverse viral integration sites. High-throughput compound screening with this model identified ACY-1215 as a potent latency reversing agent, which could be verified in other cell models and in primary CD4+ T cells from ART-suppressed individuals ex vivo. In summary, we have generated a meaningful and feasible model to directly study latently infected cells, which could open up new avenues to explore the critical events of HIV-1 latency and become a valuable tool for the research of AIDS functional cure.